JenniferJohnsonMDPhD, FACP

Oncology • Philadelphia, PA

Head & Neck Cancer, Thoracic Cancer

Associate Professor

Join to view full profile

Dr. Johnson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Johnson's full profile

Already have an account?

Office
1025 walnut street
700
Philadelphia, PA 19107

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2012 - 2015
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHChief Residency, Internal Medicine, 2011 - 2012
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 2008 - 2011
University of Pittsburgh School of MedicineClass of 2008

Certifications & Licensure

DE State Medical License 2017 - 2025
NJ State Medical License 2017 - 2025
PA State Medical License 2008 - 2024
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Outstanding Teaching Fellow Thomas Jefferson University, 2012
Outstanding Teaching Resident Thomas Jefferson University, 2010
Humaneness in Medicine Philadelphia County Medical Society, 2008

Publications & Presentations

PubMed

36 citations
Association Between Sex and Immune Checkpoint Inhibitor Outcomes for Patients With Melanoma.
Se Ryeong Jang, Nikita Nikita, Joshua Banks, Scott W. Keith, Jennifer Johnson
JAMA Network Open. 2021-12-01
26 citations
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...
Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield
Cancer Medicine. 2021-09-01
49 citations
MCT1 in Invasive Ductal Carcinoma: Monocarboxylate Metabolism and Aggressive Breast Cancer.
Jennifer Johnson, Paolo Cotzia, Roberto Fratamico, Lekha Mikkilineni, Jason Chen
Frontiers in Cell and Developmental Biology. 2017-04-03

Lectures

Safety of nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

Taproot Health Launches National Oncology Database to Advance Precision MedicineJanuary 3rd, 2020
Rakuten Medical Releases New, Post-Hoc Analysis of Safety, Pharmacokinetic (PK), Immunogenicity and Biomarker Data from Its Phase 1 & 1/2a Clinical TrialsNovember 2nd, 2019
Targeting Breast Cancer Metabolism to Fight the DiseaseNovember 28th, 2016